Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Azul Optics is a medical technology company based in Bristol, UK, that specializes in developing advanced diagnostic tools for eye health. The company's flagship product is a compact, rapid-assessment device designed to measure macular pigment optical density (MPOD), which serves as a critical biomarker for the risk of developing age-related macular degeneration (AMD). By utilizing proprietary polarized light technology originally researched at the University of Bristol, the device allows eye care professionals to identify at-risk patients and monitor the effectiveness of nutritional interventions. Azul Optics aims to make preventative eye care more accessible through affordable and easy-to-use screening solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Azul Optics.